Artículo de Revisión
in predicting risk of fractures in patients
with inflammatory bowel disease: A
systematic review. J Clin Densitom 2017;
20: 180-7.
60.- Legido J, Gisbert J, Maté J. Bone
metabolism changes in 100 patients
with inflammatory bowel disease.
Gastroenterol Hepatol 2011; 34: 379-84.
61.- Ghishan F, Kiela P. Advances in the
understanding of mineral and bone
metabolism in inflammatory bowel
diseases. Am J Physiol Gastrointest Liver
Physiol 2011; 300: G191-201.
62.- Terzoudis S, Malliaraki N, Damilakis J,
Dimitriadou D, Zavos C, Koutroubakis
I. Chemerin, visfatin, and vaspin serum
levels in relation to bone mineral density
in patients with inflammatory bowel
disease. Eur J Gastroenterol Hepatol
2016; 28: 814-9.
63.- Duggan SN, Smyth N, Murphy A,
Macnaughton D, O’Keefe S, Conlon K.
High prevalence of osteoporosis in
patients with chronic pancreatitis: a
systematic review and meta-analysis.
Clin Gastroenterol Hepatol 2014; 12:
219-28.
176
Osteopo rosis . Parte II: en enfe rmedades hep áticas y de l tubo diges tivo - J. C. Weitz V. et al.
64.- Prabhakaran A, Bhasin D, Rana S,
Bhadada S, Bhansali A, Rao C, et al.
Bone mineral metabolism and bone
mineral density in alcohol related and
idiopathic chronic pancreatitis. Trop
Gastroenterol 2014; 35: 107-12.
65.- Hoogenboom S, Lekkerkerker S,
Fockens P, Boermeester M, van Hooft J.
Systematic review and meta-analysis on
the prevalence of vitamin D deficiency
in patients with chronic pancreatitis.
Pancreatology 2016; 16: 800-6.
66.- Yu E, Bauer S, Bain P, Bauer D. Proton
pump inhibitors and risk of fractures: a
meta-analysis of 11 international studies.
Am J Med 2011; 124: 519-26.
67.- Ngamruengphong S, Leontiadis GI,
Radhi S, Dentino A, Nugent K. Proton
pump inhibitors and risk of fracture: a
systematic review and meta-analysis of
observational studies. Am J Gastroenterol
2011; 106: 1209-18.
68.- Ye W, Liu H, Wu C. Proton pump
inhibitors therapy and risk of hip fracture:
a systematic review and meta-analysis.
Eur J Gastroenterol Hepatol 2011; 23:
794-800.
69.- O’Connell M, Madden D, Murray A,
Heaney R, Kerzner L. Effects of proton
pump inhibitors on calcium carbonate
absorption in women: a randomized
crossover trial. Am J Med 2005; 118:
778-81.
70.- Matuszewska A, Nowak B. Effects of
long-term administration of panzoprazole
on bone mineral density in young male
rats. Pharmacol Rep 2016; 68: 1060-4.
71.- Guañabens N, Parés A. Management
of osteoporosis in liver disease. Clin
Res Hepatol Gastroenterol 2011; 35:
438-45.
72.- Thompson A, Siminoski K, Fried M,
Sáenz R, Cohen H, Elewaut A, et al.
WGO Practice Guideline Osteoporosis
and gastrointestinal diseases.Disponible
en: http://f.imd.com/medinfo/material/
ca4/4ea7ceee44ae1efe2b1ceca4/4ea7
ceee44ae1efe2b1ceca7.pdf (Consultado
el 15 de abril de 2017).
73.- Bernstein CN, Leslie WD,
Leboff M. AGA technical review
on osteoporosis in gastrointestinal
diseases. Gastroenterology 2003; 124:
795-841.
Gastroenterol. latinoam 2017; Vol 28, Nº 3: 170-176